% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@PHDTHESIS{Siebel:62156,
author = {Siebel, Philip},
othercontributors = {Hegele-Hartung, Christa},
title = {{D}ie {W}irkung von selektiven Östrogenrezeptor [alpha]
und [beta]-{A}gonisten auf {O}var und {U}terus am
{N}agetier},
address = {Aachen},
publisher = {Publikationsserver der RWTH Aachen University},
reportid = {RWTH-CONV-123746},
pages = {112 S. : Ill., graph. Darst.},
year = {2005},
note = {Aachen, Techn. Hochsch., Diss., 2005},
abstract = {Novel isotype selective estrogen receptor (ER) agonists,
the selective ERAlphaagonist 16Alpha-LE2 and the selective
ERBeta agonist 8Beta-VE2, were used in hypophysectomized
rats or GnRH antagonist treated immature mice as well as in
ovariectomized mature rats to elucidate the effect of
subtype selective estrogens on the physiology of ovarian
folliculogenesis, uterine proliferation and gene regulation,
respectively. In immature hypophysectomized animals, the
ERBeta agonist and the reference compound 17Beta-estradiol
caused stimulation of early folliculogenesis, a decrease in
follicular atresia and induction of ovarian gene expression.
The ERBeta agonist exhibited the same efficiency and a
similar high potency as 17Beta-estradiol in the respective
studies. In contrast, the ERAlphaagonist had little or no
effect on these parameters implying that direct estrogen
effects on ovarian follicular development and gene
regulation are mediated by ERBeta. In ovariectomized mature
rats the ERAlpha agonist and the reference compound
17Beta-estradiol caused stimulation of uterine weight, cell
proliferation and cell-compartment dependant gene
regulation. The ERAlpha agonist exhibited the same
efficiency and a similar high potency as 17Beta-estradiol in
the respective studies. On the other hand, the ERBeta
agonist did not stimulate uterine weight and cell
proliferation in intact female rats and had no effect on
gene regulation, showing that estrogen receptor Alpha is the
dominant receptor in the uterus and responsible for
mediating direct estrogen effects. This is in line with the
assumption that stimulation of uterine growth and other
known estrogen effects are mediated by ERAlpha but not by
ERBeta and that ovarian ERBeta dominance is responsible for
increased stimulation of folliculogenesis. This unique
endocrine profile of selective estrogen receptor agonists
provides new options for targeted pharmacotherapeutical
indications as for example tailoring classical ovarian
stimulation protocols by the use of ERBeta agonists or
inventing new contraceptive agents by inhibition via an
action on the hypothalamic-pituitary-ovarian axis by the use
of ERAlpha agonists.},
cin = {510000-1},
ddc = {610},
cid = {$I:(DE-82)510000-1_20140620$},
typ = {PUB:(DE-HGF)11},
urn = {urn:nbn:de:hbz:82-opus-12124},
url = {https://publications.rwth-aachen.de/record/62156},
}